207 related articles for article (PubMed ID: 20541539)
1. Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.
Li F; Patterson AD; Höfer CC; Krausz KW; Gonzalez FJ; Idle JR
Biochem Pharmacol; 2010 Oct; 80(7):1063-74. PubMed ID: 20541539
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics.
Li F; Patterson AD; Höfer CC; Krausz KW; Gonzalez FJ; Idle JR
Biochem Pharmacol; 2011 Apr; 81(8):1043-53. PubMed ID: 21300029
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of amiodarone metabolites in rats using UPLC-ESI-QTOFMS-based untargeted metabolomics approach.
Jeong ES; Kim G; Yim D; Moon KS; Lee SJ; Shin JG; Kim DH
J Toxicol Environ Health A; 2018; 81(12):481-492. PubMed ID: 29641932
[TBL] [Abstract][Full Text] [Related]
4. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats.
Johnson CH; Patterson AD; Krausz KW; Lanz C; Kang DW; Luecke H; Gonzalez FJ; Idle JR
Radiat Res; 2011 Apr; 175(4):473-84. PubMed ID: 21309707
[TBL] [Abstract][Full Text] [Related]
5. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.
Patterson AD; Maurhofer O; Beyoglu D; Lanz C; Krausz KW; Pabst T; Gonzalez FJ; Dufour JF; Idle JR
Cancer Res; 2011 Nov; 71(21):6590-600. PubMed ID: 21900402
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
[TBL] [Abstract][Full Text] [Related]
7. Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS.
Aleksa K; Nava-Ocampo A; Koren G
Chirality; 2009 Jul; 21(7):674-80. PubMed ID: 18825700
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of dehydrodiisoeugenol using xenobiotic metabolomics.
Lv QQ; Yang XN; Yan DM; Liang WQ; Liu HN; Yang XW; Li F
J Pharm Biomed Anal; 2017 Oct; 145():725-733. PubMed ID: 28806569
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
Roy C; Tremblay PY; Bienvenu JF; Ayotte P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture.
Mohrmann M; Ansorge S; Schmich U; Schönfeld B; Brandis M
Pediatr Nephrol; 1994 Apr; 8(2):157-63. PubMed ID: 7517170
[TBL] [Abstract][Full Text] [Related]
11. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.
Liu A; Patterson AD; Yang Z; Zhang X; Liu W; Qiu F; Sun H; Krausz KW; Idle JR; Gonzalez FJ; Dai R
Drug Metab Dispos; 2009 Jun; 37(6):1157-63. PubMed ID: 19251819
[TBL] [Abstract][Full Text] [Related]
13. A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice.
Wang YK; Yang XN; Liang WQ; Xiao Y; Zhao Q; Xiao XR; Gonzalez FJ; Li F
Xenobiotica; 2019 Jun; 49(6):655-670. PubMed ID: 29897827
[TBL] [Abstract][Full Text] [Related]
14. A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism.
Loqueviel C; Malet-Martino M; Martino R
Cell Mol Biol (Noisy-le-grand); 1997 Jul; 43(5):773-82. PubMed ID: 9298599
[TBL] [Abstract][Full Text] [Related]
15. Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.
Česen M; Kosjek T; Busetti F; Kompare B; Heath E
Environ Sci Pollut Res Int; 2016 Jun; 23(11):11209-11223. PubMed ID: 26920534
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
Mills KA; Chess-Williams R; McDermott C
Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
[TBL] [Abstract][Full Text] [Related]
18. Optimization of extraction and analytical protocol for mass spectrometry-based metabolomics analysis of hepatotoxicity.
Yang R; Zhao Q; Hu DD; Xiao XR; Li F
Biomed Chromatogr; 2018 Dec; 32(12):e4359. PubMed ID: 30091800
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive profiling of semi-polar phytochemicals in whole wheat grains (Triticum aestivum) using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry.
Tais L; Schulz H; Böttcher C
Metabolomics; 2021 Jan; 17(2):18. PubMed ID: 33502591
[TBL] [Abstract][Full Text] [Related]
20. Surface-activated chemical ionization-electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid.
Puccio G; Brambilla P; Conti M; Bartolini D; Noonan D; Albini A
Rapid Commun Mass Spectrom; 2013 Feb; 27(3):476-80. PubMed ID: 23280980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
